Metraipolis › archive › dc_85bc3410b658
Effectiveness of Rituximab, Belimumab, and Thrombopoietin Receptor Agonists in Refractory Immune Thrombocytopenia Associated With Systemic Lupus… — Europe PMC PMID:41536373
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41536373
- DOI
- 10.7759/cureus.99214
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T11:00:30.350Z
- SHA-256 of the archived text
c7f254cb02d7f6797e9733ef87e5874ee1bc73094994f046e794c840209ec0ea- Stable URL of this page
https://metraipolis.com/documento/dc_85bc3410b658
How to cite
Effectiveness of Rituximab, Belimumab, and Thrombopoietin Receptor Agonists in Refractory Immune Thrombocytopenia Associated With Systemic Lupus… — Europe PMC PMID:41536373 — Europe PMC (en), https://europepmc.org/article/MED/41536373 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_85bc3410b658 (Metraipolis archive dc_85bc3410b658, sha256 c7f254cb02d7f6797e9733ef87e5874ee1bc73094994f046e794c840209ec0ea)
BibTeX
@misc{dc85bc3410b658,
title = {Effectiveness of Rituximab, Belimumab, and Thrombopoietin Receptor Agonists in Refractory Immune Thrombocytopenia Associated With Systemic Lupus… — Europe PMC PMID:41536373},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41536373},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_85bc3410b658; sha256 c7f254cb02d7f6797e9733ef87e5874ee1bc73094994f046e794c840209ec0ea},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41536373. Agents can read the archived copy with the MCP tool read_document.